<DOC>
	<DOC>NCT02379637</DOC>
	<brief_summary>This study is designed to improve knowledge regarding the initial effectiveness of N-acetylcysteine (NAC) on cold and cough symptoms.</brief_summary>
	<brief_title>Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and Cough</brief_title>
	<detailed_description />
	<mesh_term>Cough</mesh_term>
	<mesh_term>Common Cold</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Cold/URTI symptoms occurring no more than 4 days cough due to a cold or acute viral (URTI) with an onset of no more than 3 days cough frequency with specified cutoff A subchronic, or chronic cough (cough duration &gt; 2 months) due to any condition other than a cold/URTI Diagnosed as suffering from any pulmonary conditions associated with cough, e.g., chronic obstructive pulmonary disease (COPD), acute or chronic bronchitis, asthma, cystic fibrosis Taking any medications known to induce cough Fever of greater than 39°C (102°F) orally Complication of the common cold like otitis media, severe sinusitis, or pneumonia Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>N-acetylcysteine</keyword>
	<keyword>adults</keyword>
	<keyword>cough and cold</keyword>
</DOC>